Coherus BioSciences

+$0.48 (+3.42%) Today

-$0.20 (-1.38%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CHRS and other stocks, options, and ETFs commission-free!

About CHRS

Coherus BioSciences, Inc. Common Stock, also called Coherus BioSciences, is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics.

CEO

Denny M. Lanfear

Employees

317

Headquarters

Redwood City, California

Founded

2010

CHRS Key Statistics

Market Cap

1.10B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

819.73K

High Today

$14.50

Low Today

$14.10

Open Price

$14.26

Volume

741.97K

52 Week High

$22.22

52 Week Low

$12.90

Analyst Ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

CHRS Earnings

$0.00

$0.27

$0.54

$0.81

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 5, After Hours